Anti Epilepsy Drugs Market 2015 to 2022 – Market Share, Growth, Statistics, Competitor Landscape, Key Players Analysis, Trends and Forecasts

“Global Anti-Epilepsy Drugs market”
Global anti-epilepsy drugs market Information, Types of seizures (Generalized seizures and Partial-onset seizures), By Generation (First, second and third) – Forecast to 2022

Market Highlights:

Anti Epilepsy Drugs are used for the treatment of epilepsy which is a group of neurological disorders characterized by seizures manifesting as brief, involuntary episodes of vigorous body movements with or without loss of consciousness which affects about 24 million people. The present market of anti-epilepsy drugs is valued at USD 3.7 billion in 2015. The projected growth is USD 4.8 billion in 2022 representing a CAGR of 3.79%.

The Anti Epilepsy Drug Market is characterised by flat growth rate due to lack of novel acting anti-epileptic drugs. Thus, the market is full of drugs having similar mechanism of action and similar side effects. Moreover a large segment of patients do not respond well to these drugs. The anti-epilepsy drug market will favour companies with development pipeline of novel acting drug class. The market is fragmented and has a number of generics with a large number of companies.

Test the market data and market information presented through more than 60 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Anti Epilepsy Drug Market Research Report – Forecast to 2022”.

Major Key Players:

  • Pfizer, Inc.
  • Johnson & Johnson
  • UCB Pharma Ltd.
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Novartis International AG
  • Sanofi S.A.
  • Shire Pharmaceuticals Limited
  • Cephalon Inc.

Request a Sample Report @

Regional Analysis:

Depending on geographic region, anti-epilepsy drugs market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally Americas is the largest market for anti-epilepsy drugs as there is rapid development in technology and has willingness to adopt innovative products for emergency care and chronic & acute diseases are some of the key factors projected to driving the growth of anti-epilepsy drugs market in this region. Europe is the second-largest market for anti-epilepsy drugs. Asia pacific region is expected to be fastest growing region in anti-epilepsy drugs market.

Thus the market of anti-epilepsy drugs in developed countries will be flat until the advent of novel anti-epileptic drug. Developing regions will consistently increase the share for second and third generation drugs.


Global anti-epilepsy drugs market has been segmented on the basis of types of seizures (generalized seizures and partial-onset seizures) and by generation (first, second and third).

This report includes a study of strategies, of major market players. It includes the product portfolios, developments of leading major players such as: Pfizer, Inc., Johnson & Johnson, UCB Pharma Ltd., Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Shire Pharmaceuticals Limited and Cephalon Inc.

This research report has provided the insights, on various levels of analysis such as industry analysis, market share analysis leading market players and their profiles. This report also helps in studying the target segments by providing views on emerging & high-growth segments and market conclusion.

Study Objectives Global Anti Epilepsy Drugs Market:

  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global anti-epilepsy drugs market  
  • To provide insights about factors affecting the market growth
  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To provide country level analysis of the market for segments by type of seizures (seizures (generalized seizures and partial-onset seizures) and by generation (first, second and third)
  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Access Report Details @

Intended Audience:

  • Global anti-epilepsy drugs manufacturers
  • Global anti-epilepsy drugs suppliers
  • Research and development Laboratories
  • Market Research and Consulting Service Providers

The report for Global Anti Epilepsy Drugs Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions. 

Table of Contents

 1         Introduction

1.1       Definition

1.2       Scope Of Study

1.3       Research Objective

1.4       Assumptions & Limitations

1.5       Market Structure

2          Research Methodology

2.1       Research Process

2.2       Primary Research

2.3       Secondary Research

3          Market Dynamics

3.1       Drivers

3.2       Restraints

3.3       Opportunities

3.4       Challenges

3.5       Macroeconomic Indicators

4          Market Factor Analysis

4.1       Porter’s Five Forces Model

4.1.1    Bargaining Power Of Suppliers

4.1.2    Bargaining Power Of Customer

4.1.3    Intensity Of Competitor’s

4.1.4    Threat Of New Entrants

5          Global Anti-Epilepsy Drugs Market, By Types Of Seizures  

5.1       Introduction 

5.1.1    Generalized Seizures

5.1.2    Partial-Onset Seizures

5.1.3    Others


List of Tables

Table 1    Global Anti-Epilepsy Drugs Market, 2013-2022 (Usd Million)

Table 2    Global Anti-Epilepsy Drugs Market, 2013-2022 (Usd Million)

Table 3    Global Anti-Epilepsy Drugs Market, 2013-2022 (Usd Million)

Table 4    Global Anti-Epilepsy Drugs Market, 2013-2022 (Usd Million)

List of Figures

Figure 1    Research Process

Figure 2    Porters Five Forces Model

Figure 3    Global Anti-Epilepsy Drugs Market, By Types Of Seizures

Figure 4    Global Anti-Epilepsy Drugs Market, By Generation

Figure 5    Global Anti-Epilepsy Drugs Market, By Region

Figure 6    Global Anti-Epilepsy Drugs Market: Company Share Analysis, 2015 (%)  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
City: Pune
State: Maharashtra
Country: India